SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Dr. Juan Manuel Pérez - 26 May, 2026 0

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

Dr. Juan Manuel Pérez - 25 May, 2026 0

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

Dr. Andrés Rodríguez - 22 May, 2026 0

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

Noticias Institucionales

06/03 | SOLACI Technicians & Nurses Webinar – Clinical Impact of Structural Interventions: TAVI and MitraClip in Current Practice

solaci - 28 May, 2026 0

The Latin American Society of Interventional Cardiology (SOLACI), through its Technicians and Nurses Department, invites you to participate in a new scientific webinar entitled...

SOLACI Presented an Outstanding Scientific Session on Complex Coronary Lesions at EuroPCR 2026

solaci - 22 May, 2026 0

The Latin American Society of Interventional Cardiology (SOLACI) had a prominent participation at EuroPCR 2026 through an institutional scientific session held on May 21...

Relive SOLACI’s participation in the V International Congress of Clinical and Interventional Cardiology in the Dominican Republic

solaci - 21 May, 2026 0

The Latin American Society of Interventional Cardiology actively participated in the “V International Congress of Clinical and Interventional Cardiology”, organized by the Asociación Dominicana...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad

Tag: clopidogrel

Diabetes and Peripheral Vascular Disease: Old Drugs, New Evidence

The most relevant articles in pharmacology in 2020

AHA 2020 | Clopidogrel Resists as the Best Option in Elective...

Antiplatelet Therapy in Elderly Population: Are the New P2Y12 Inhibitors Safe?

Virtual ACC 2020 | POPULAR TAVR: Post TAVR Anticoagulation without Clopidogrel?

Virtual ACC 2020 | TAILOR-PCI: Gene-Based Prescribing of Clopidogrel Does Not...

ESC 2019 | POPULAR AGE: Good Old Clopidogrel Still Valid

EuroPCR 2019 | Global Leaders: Ticagrelor Monotherapy at Long Term Could...

ACC 2019 | STOPDAPT-2: P2Y12 Monotherapy After Short-Term Dual Antiplatelet Therapy After...

ACC 2019 | SMART-CHOICE: Aspirin Increasingly “Against the Ropes”